Published in Prog Urol on March 01, 2010
Recombinant human interleukin-2, recombinant human interferon alfa-2a, or both in metastatic renal-cell carcinoma. Groupe Français d'Immunothérapie. N Engl J Med (1998) 4.93
Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS) - update 2008. Ultraschall Med (2008) 3.49
Proteinase K from Tritirachium album Limber. Eur J Biochem (1974) 3.41
EFSUMB guidelines and recommendations on the clinical use of ultrasound elastography. Part 2: Clinical applications. Ultraschall Med (2013) 2.93
EFSUMB guidelines and recommendations on the clinical use of ultrasound elastography. Part 1: Basic principles and technology. Ultraschall Med (2013) 2.73
Sequential sorafenib and sunitinib for renal cell carcinoma. J Urol (2009) 2.12
Negative impact of bone metastasis on outcome in clear-cell renal cell carcinoma treated with sunitinib. Ann Oncol (2010) 2.11
Small solid renal masses: characterization by diffusion-weighted MRI at 3 T. Clin Radiol (2013) 2.08
Prognostic factors of survival and rapid progression in 782 patients with metastatic renal carcinomas treated by cytokines: a report from the Groupe Français d'Immunothérapie. Ann Oncol (2002) 2.03
Benefit of cytoreductive nephrectomy in metastatic RCC: do we learn from retrospective studies and small prospective studies? Ann Oncol (2011) 2.03
Low body mass index and sarcopenia associated with dose-limiting toxicity of sorafenib in patients with renal cell carcinoma. Ann Oncol (2010) 1.91
Laparoscopic radical prostatectomy: oncological evaluation after 1,000 cases a Montsouris Institute. J Urol (2003) 1.90
Response rate accuracy in oncology trials: reasons for interobserver variability. Groupe Français d'Immunothérapie of the Fédération Nationale des Centres de Lutte Contre le Cancer. J Clin Oncol (1997) 1.77
De novo kidney graft tumors: results from a multicentric retrospective national study. Am J Transplant (2012) 1.74
[German S3-guideline "Diagnosis and treatment of esophagogastric cancer"]. Z Gastroenterol (2011) 1.74
Transperitoneal or extraperitoneal approach for laparoscopic radical prostatectomy: a false debate over a real challenge. J Urol (2004) 1.74
Guidelines for the use of contrast agents in ultrasound. January 2004. Ultraschall Med (2004) 1.68
Targeted agents in metastatic Xp11 translocation/TFE3 gene fusion renal cell carcinoma (RCC): a report from the Juvenile RCC Network. Ann Oncol (2010) 1.65
MAGE-A4, a germ cell specific marker, is expressed differentially in testicular tumors. Cancer (2001) 1.65
Patient-reported outcomes for axitinib vs sorafenib in metastatic renal cell carcinoma: phase III (AXIS) trial. Br J Cancer (2013) 1.65
Combining carboplatin and etoposide in docetaxel-pretreated patients with castration-resistant prostate cancer: a prospective study evaluating also neuroendocrine features. Ann Oncol (2009) 1.57
Complications of transperitoneal laparoscopic surgery in urology: review of 1,311 procedures at a single center. J Urol (2002) 1.50
Renal blood flow quantification in pigs using contrast-enhanced ultrasound: an ex vivo study. Ultraschall Med (2010) 1.47
[The role of diffusion 3-Tesla MRI in detecting prostate cancer before needle biopsy: multiparametric study of 111 patients]. J Radiol (2010) 1.43
Heat and moisture exchanger vs heated humidifier during long-term mechanical ventilation. A prospective randomized study. Chest (1991) 1.43
[Recommendations for the treatment of prostate cancer in the elderly man: A study by the oncology committee of the French association of urology]. Prog Urol (2009) 1.40
Haemodynamic changes during retroperitoneoscopic adrenalectomy for phaeochromocytoma. Br J Anaesth (2001) 1.38
[The laparoscopic nephrectomy for polycystic kidney is feasible and reproducible]. Prog Urol (2013) 1.38
High detection rate of circulating tumor cells in blood of patients with prostate cancer using telomerase activity. Ann Oncol (2007) 1.35
Leber's hereditary optic neuroretinopathy, a mitochondrial disease? Lancet (1984) 1.34
Final results of the European Advanced Renal Cell Carcinoma Sorafenib (EU-ARCCS) expanded-access study: a large open-label study in diverse community settings. Ann Oncol (2011) 1.34
Ouabain application to the round window of the gerbil cochlea: a model of auditory neuropathy and apoptosis. J Assoc Res Otolaryngol (2001) 1.31
Insulin detemir used in basal-bolus therapy in people with type 1 diabetes is associated with a lower risk of nocturnal hypoglycaemia and less weight gain over 12 months in comparison to NPH insulin. Diabetes Obes Metab (2005) 1.30
Gene deletions in X-linked muscular dystrophy. Am J Hum Genet (1989) 1.29
An EFSUMB introduction into Dynamic Contrast-Enhanced Ultrasound (DCE-US) for quantification of tumour perfusion. Ultraschall Med (2012) 1.29
Everolimus in metastatic renal cell carcinoma: Subgroup analysis of patients with 1 or 2 previous vascular endothelial growth factor receptor-tyrosine kinase inhibitor therapies enrolled in the phase III RECORD-1 study. Eur J Cancer (2011) 1.29
Characterization of a G protein-coupled receptor for nicotinic acid. Mol Pharmacol (2001) 1.28
[A glucose dehydrogenase for the determination of glucose concentrations in body fluids (author's transl)]. Z Klin Chem Klin Biochem (1975) 1.26
X-linked myopathy with excessive autophagy: a new hereditary muscle disease. Ann Neurol (1988) 1.26
Prognostic factors for survival in 1059 patients treated with sunitinib for metastatic renal cell carcinoma. Br J Cancer (2013) 1.24
Inhibition of IKs in guinea pig cardiac myocytes and guinea pig IsK channels by the chromanol 293B. Pflugers Arch (1996) 1.24
Immunisation of metastatic cancer patients with MAGE-3 protein combined with adjuvant SBAS-2: a clinical report. Eur J Cancer (2003) 1.21
Prognostic factors for survival in patients with brain metastases from renal cell carcinoma. Cancer (1998) 1.18
First-line bevacizumab combined with reduced dose interferon-alpha2a is active in patients with metastatic renal cell carcinoma. Ann Oncol (2008) 1.18
Coping, distress, and survival among patients with lung cancer. Arch Gen Psychiatry (1999) 1.17
Prognostic significance of the mode of detection in renal tumours. BJU Int (2002) 1.17
Long-term experience after ex situ liver surgery. Surgery (2000) 1.16
Optimizing the size variation threshold for the CT evaluation of response in metastatic renal cell carcinoma treated with sunitinib. Ann Oncol (2009) 1.15
Which is the best surgery for Budd-Chiari syndrome: venous decompression or liver transplantation? A single-center experience with 50 patients. Hepatology (1995) 1.13
Meta-analysis of tumor recurrence after liver transplantation for hepatocellular carcinoma based on 1,198 cases. Eur J Med Res (2007) 1.13
Free human chorionic gonadotropin beta subunit in gonadal and nongonadal neoplasms. Cancer Res (1992) 1.13
Laparoscopic partial nephrectomy for renal tumor: single center experience comparing clamping and no clamping techniques of the renal vasculature. J Urol (2003) 1.12
Ultraviolet-light-induced conformational changes in DNA. Photochem Photobiol (1973) 1.10
AKT and ERK1/2 signaling in intrahepatic cholangiocarcinoma. World J Gastroenterol (2007) 1.10
Costs of managing adverse events in the treatment of first-line metastatic renal cell carcinoma: bevacizumab in combination with interferon-alpha2a compared with sunitinib. Br J Cancer (2009) 1.09
Angiotensin-2 receptors (AT1-R and AT2-R), new prognostic factors for renal clear-cell carcinoma? Br J Cancer (2010) 1.08
Survival of patients with initially unresectable colorectal liver metastases treated with FOLFOX/cetuximab or FOLFIRI/cetuximab in a multidisciplinary concept (CELIM study). Ann Oncol (2014) 1.07
"PMN-elastase assay": enzyme immunoassay for human polymorphonuclear elastase complexed with alpha 1-proteinase inhibitor. J Clin Chem Clin Biochem (1984) 1.07
Effectiveness of simple measures to control an outbreak of nosocomial methicillin-resistant Staphylococcus aureus infections in an intensive care unit. Infect Control Hosp Epidemiol (1990) 1.07
Retrospective analysis of prognostic factors after liver resection and transplantation for cholangiocellular carcinoma. Br J Surg (2000) 1.06
Monoclonal antibodies against inhibin represent key markers of adult granulosa cell tumors of the ovary even in their metastases. A report of three cases with late metastasis, being previously misinterpreted as hemangiopericytoma. Am J Surg Pathol (1995) 1.06
Creatine kinase, an enzyme of many forms. Clin Chem (1982) 1.06
Proximal versus distal gastric carcinoma--what are the differences? Ann Surg Oncol (2000) 1.05
Pre-attentive detection of vowel contrasts utilizes both phonetic and auditory memory representations. Brain Res Cogn Brain Res (1999) 1.03
Absence of VHL gene alteration and high VEGF expression are associated with tumour aggressiveness and poor survival of renal-cell carcinoma. Br J Cancer (2009) 1.03
Exosomes for cancer immunotherapy. Ann Oncol (2004) 1.03
Therapeutic mTOR inhibition in autosomal dominant polycystic kidney disease: What is the appropriate serum level? Am J Transplant (2010) 1.03
Adeno-associated virus-mediated gene delivery into the scala media of the normal and deafened adult mouse ear. Gene Ther (2011) 1.03
Natural history of residual renal stone fragments after ESWL. Eur Urol (2000) 1.02
[Determination of creatine kinase-MB in serum using inhibiting antibodies (author's transl)]. Klin Wochenschr (1976) 1.00
Surgery as primary treatment in patients with liver metastases from carcinoid tumors: a retrospective, unicentric study over 13 years. Surgery (2001) 1.00
Identification of genital tract markers in the human seminal plasma using an integrative genomics approach. Hum Reprod (2012) 0.99
[Diagnosis and treatment of colorectal liver metastases - workflow]. Zentralbl Chir (2008) 0.98
Incidence of brain metastases in renal cell carcinoma treated with sorafenib. Ann Oncol (2009) 0.98
Classifications in routine use: lessons from ICD-9 and ICPM in surgical practice. J Am Med Inform Assoc (2001) 0.97
Predictors of clinical response to interleukin-2--based immunotherapy in melanoma patients: a French multiinstitutional study. J Clin Oncol (1996) 0.97
Cytokines and soluble cytokine receptor induction after IL-12 administration in cancer patients. Clin Exp Immunol (2000) 0.97
Activation of various subtypes of G-protein alpha subunits by partial agonists of the adenosine A1 receptor. Biochem Pharmacol (1998) 0.97
Preoperative volume prediction in adult living donor liver transplantation: how much can we rely on it? Am J Transplant (2007) 0.97
Quantitative analysis of individual motor unit potentials: a proposition for standardized terminology and criteria for measurement. J Clin Neurophysiol (1986) 0.96
Severity-of-illness scores for neutropenic cancer patients in an intensive care unit: Which is the best predictor? Do multiple assessment times improve the predictive value? Crit Care Med (1998) 0.96
Levels of circulating CD45(dim)CD34(+)VEGFR2(+) progenitor cells correlate with outcome in metastatic renal cell carcinoma patients treated with tyrosine kinase inhibitors. Br J Cancer (2011) 0.96
Determination of creatine kinase isoenzyme MB activity in serum using immunological inhibition of creatine kinase M subunit activity. Activity kinetics and diagnostic significance in myocardial infarction. Clin Chim Acta (1976) 0.96
Second non-germ cell malignancies in patients treated for stage I-II testicular seminoma. Radiother Oncol (1999) 0.95
Angiogenic characteristics of circulating and tumoural thrombospondin-1 in breast cancer. Int J Oncol (2007) 0.95
Radical cystectomy in patients older than 75 years: assessment of morbidity and mortality. Eur Urol (2001) 0.95
Long-term impact of subclinical inflammation diagnosed by protocol biopsy one year after renal transplantation. Am J Transplant (2011) 0.94
Involvement of the central nervous system in acute, uncomplicated measles virus infection. J Clin Microbiol (1980) 0.94
Prognostic factors for neutropenic patients in an intensive care unit: respective roles of underlying malignancies and acute organ failures. Eur J Cancer (1997) 0.94
Disease course after liver transplantation for hepatocellular carcinoma in patients with complete tumor necrosis in liver explants after performance of bridging treatments. Eur J Med Res (2005) 0.94
Ex-vivo resection techniques in tissue-preserving surgery for liver malignancies. Langenbecks Arch Surg (2000) 0.93
Treatment and prophylaxis of severe infections in neutropenic patients by granulocyte transfusions. Ann Hematol (2002) 0.93
Northern epilepsy syndrome: an inherited childhood onset epilepsy with associated mental deterioration. J Med Genet (1994) 0.93
Aneurysm of the superior mesenteric vein. Radiology (1982) 0.92
Evidence for B-C transition in ultraviolet-irradiated DNA. An infrared linear dichroism study. Biochim Biophys Acta (1976) 0.92
The postchemotherapy PSA surge syndrome. Ann Oncol (2008) 0.92